News BI, Click Therapeutics expand collaboration to PDT for schiz... Boehringer Ingelheim (BI) and Click Therapeutics have announced they are expanding their
News Controversial project aims to make artificial human genomes A landmark project funded by Wellcome aims to develop the tools needed to synthesise human genomes – and simultaneously probe the social implications.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
